Gregory Renza
Stock Analyst at Truist Financial
(4.84)
# 425
Out of 5,023 analysts
855
Total ratings
53.9%
Success rate
17.7%
Average return
Main Sectors:
Stocks Rated by Gregory Renza
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| REGN Regeneron Pharmaceuticals | Reiterated: Buy | $772 | $735.20 | +5.01% | 14 | Oct 2, 2026 | |
| MNKD MannKind | Reiterated: Buy | $6 | $3.80 | +57.89% | 40 | Sep 30, 2026 | |
| ZYME Zymeworks | Reiterated: Buy | $32 | $25.15 | +27.24% | 7 | Sep 29, 2026 | |
| XNCR Xencor | Reiterated: Buy | $29 | $24.84 | +16.75% | 35 | Sep 28, 2026 | |
| AMGN Amgen | Reiterated: Hold | n/a | $403.04 | - | 43 | Sep 23, 2026 | |
| VKTX Viking Therapeutics | Reiterated: Buy | $83 → $87 | $29.94 | +190.58% | 3 | Sep 23, 2026 | |
| ABVX ABIVAX Société Anonyme | Reiterated: Buy | $155 → $151 | $92.88 | +62.58% | 13 | Sep 22, 2026 | |
| CATX Perspective Therapeutics | Reiterated: Buy | n/a | $2.76 | - | 20 | Sep 15, 2026 | |
| NUVB Nuvation Bio | Reiterated: Buy | n/a | $5.14 | - | 29 | Sep 15, 2026 | |
| EXEL Exelixis | Reiterated: Hold | n/a | $58.39 | - | 36 | Sep 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $67.38 | - | 23 | Sep 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $206.64 | - | 9 | Sep 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $37.36 | - | 34 | Sep 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $235.67 | - | 44 | Sep 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $19.40 | - | 37 | Sep 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $144.74 | - | 17 | Aug 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $15.37 | - | 5 | Aug 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $3.69 | - | 18 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $34.75 | - | 6 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $31.80 | - | 45 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $416 → $418 | $358.07 | +16.74% | 17 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 | $3.38 | +107.10% | 9 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 → $34 | $22.99 | +47.89% | 27 | Jul 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $19.95 | n/a | 57 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $1.13 | n/a | 24 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 | $1.16 | n/a | 36 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 | $4.38 | n/a | 23 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $7.70 | n/a | 23 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 → $46 | $0.5652 | n/a | 8 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $26 | $25.21 | n/a | 31 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $0.2872 | n/a | 15 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $13 | $7.19 | n/a | 14 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $38 | $45.71 | n/a | 26 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $2,160 → $180 | $14.99 | n/a | 11 | Jun 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20.41 | $2.33 | n/a | 23 | May 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 → $80 | $0.695 | n/a | 18 | Mar 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 → $15 | $0.000001 | n/a | 14 | Nov 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $348 | $219.88 | n/a | 1 | Sep 8, 2015 |
Regeneron Pharmaceuticals
Oct 2, 2026
Reiterated: Buy
Price Target: $772
Current: $735.20
Upside: +5.01%
MannKind
Sep 30, 2026
Reiterated: Buy
Price Target: $6
Current: $3.80
Upside: +57.89%
Zymeworks
Sep 29, 2026
Reiterated: Buy
Price Target: $32
Current: $25.15
Upside: +27.24%
Xencor
Sep 28, 2026
Reiterated: Buy
Price Target: $29
Current: $24.84
Upside: +16.75%
Amgen
Sep 23, 2026
Reiterated: Hold
Price Target: n/a
Current: $403.04
Upside: -
Viking Therapeutics
Sep 23, 2026
Reiterated: Buy
Price Target: $83 → $87
Current: $29.94
Upside: +190.58%
ABIVAX Société Anonyme
Sep 22, 2026
Reiterated: Buy
Price Target: $155 → $151
Current: $92.88
Upside: +62.58%
Perspective Therapeutics
Sep 15, 2026
Reiterated: Buy
Price Target: n/a
Current: $2.76
Upside: -
Nuvation Bio
Sep 15, 2026
Reiterated: Buy
Price Target: n/a
Current: $5.14
Upside: -
Exelixis
Sep 14, 2026
Reiterated: Hold
Price Target: n/a
Current: $58.39
Upside: -
Sep 10, 2026
Reiterated: Buy
Price Target: n/a
Current: $67.38
Upside: -
Sep 3, 2026
Reiterated: Buy
Price Target: n/a
Current: $206.64
Upside: -
Sep 1, 2026
Reiterated: Buy
Price Target: n/a
Current: $37.36
Upside: -
Sep 1, 2026
Reiterated: Buy
Price Target: n/a
Current: $235.67
Upside: -
Sep 1, 2026
Reiterated: Buy
Price Target: n/a
Current: $19.40
Upside: -
Aug 28, 2026
Reiterated: Buy
Price Target: n/a
Current: $144.74
Upside: -
Aug 21, 2026
Reiterated: Buy
Price Target: n/a
Current: $15.37
Upside: -
Aug 18, 2026
Reiterated: Hold
Price Target: n/a
Current: $3.69
Upside: -
Aug 12, 2026
Reiterated: Buy
Price Target: n/a
Current: $34.75
Upside: -
Aug 11, 2026
Reiterated: Buy
Price Target: n/a
Current: $31.80
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: $416 → $418
Current: $358.07
Upside: +16.74%
Jul 31, 2026
Reiterated: Hold
Price Target: $7
Current: $3.38
Upside: +107.10%
Jul 10, 2026
Reiterated: Buy
Price Target: $32 → $34
Current: $22.99
Upside: +47.89%
May 19, 2025
Reiterated: Buy
Price Target: $26
Current: $19.95
Upside: n/a
May 14, 2025
Reiterated: Buy
Price Target: $8
Current: $1.13
Upside: n/a
May 13, 2025
Reiterated: Hold
Price Target: $5
Current: $1.16
Upside: n/a
May 13, 2025
Reiterated: Hold
Price Target: $20
Current: $4.38
Upside: n/a
May 13, 2025
Reiterated: Buy
Price Target: $16
Current: $7.70
Upside: n/a
May 12, 2025
Reiterated: Buy
Price Target: $48 → $46
Current: $0.5652
Upside: n/a
May 8, 2025
Reiterated: Hold
Price Target: $26
Current: $25.21
Upside: n/a
May 7, 2025
Reiterated: Buy
Price Target: $16
Current: $0.2872
Upside: n/a
May 6, 2025
Reiterated: Buy
Price Target: $12 → $13
Current: $7.19
Upside: n/a
May 6, 2025
Reiterated: Hold
Price Target: $38
Current: $45.71
Upside: n/a
Jun 26, 2023
Downgraded: Hold
Price Target: $2,160 → $180
Current: $14.99
Upside: n/a
May 15, 2023
Reiterated: Hold
Price Target: $20.41
Current: $2.33
Upside: n/a
Mar 16, 2022
Reiterated: Hold
Price Target: $5 → $80
Current: $0.695
Upside: n/a
Nov 12, 2021
Reiterated: Hold
Price Target: $1 → $15
Current: $0.000001
Upside: n/a
Sep 8, 2015
Rated: Buy
Price Target: $348
Current: $219.88
Upside: n/a